mRNA-4157,Pembrolizumab
Moderna,Merck
['moderna']
at #aacr23, &amp; present new therapeutic cancer vaccine data &amp; prepare to launch phase 3 trial before end of year: via 
A Network of Centres of Excellence uniquely positioned to help Canada & the world accelerate the development of effective #cancer #immunotherapy treatments